tmem236 Antibody

What is TMEM236 and why is it significant for research?

TMEM236 (Transmembrane Protein 236) is a protein whose function was previously unknown but has recently been identified as one of the top antiviral factors against rotavirus through genome-wide CRISPR/Cas9 screens . It appears to have broad antiviral properties, not limited to rotavirus, making it a protein of significant interest for virology research. The protein consists of 351 amino acids with a molecular weight of approximately 38 kDa .

What types of TMEM236 antibodies are currently available for research?

Currently available TMEM236 antibodies include rabbit polyclonal antibodies targeting different regions of the protein. Examples include antibodies targeting the middle region (amino acids 167-216) and amino acids 150-199 . These antibodies are typically unconjugated and validated for Western Blotting applications. They are available in liquid form (supplied in PBS buffer with preservatives) or lyophilized format .

What species reactivity can be expected with TMEM236 antibodies?

Available TMEM236 antibodies show predicted reactivity across multiple species. For instance, the ABIN2792018 antibody has predicted reactivity for Human (100%), Cow (75%), Guinea Pig (75%), and Horse (75%) . Researchers should verify cross-reactivity when working with non-human models, as actual reactivity may vary depending on sequence conservation across species.

What is the optimal methodology for using TMEM236 antibodies in Western Blotting?

When using TMEM236 antibodies for Western Blotting, researchers should first determine the optimal working dilution experimentally. The antibodies are typically affinity-purified and should be stored properly to maintain efficacy (short-term at 2-8°C for up to one week; long-term at -20°C in small aliquots to prevent freeze-thaw cycles) . For best results, include positive controls when possible and optimize protein loading, transfer conditions, and blocking reagents. Since TMEM236 is a transmembrane protein, sample preparation methods that effectively solubilize membrane proteins are recommended.

How can I validate TMEM236 knockout efficiency in gene-edited cell lines?

Validation of TMEM236 knockout efficiency can be performed using multiple complementary approaches:

• Genomic verification: Confirm genetic alterations through Sanger sequencing of the targeted region

• Transcript analysis: Perform RT-qPCR using primers that target the last exons of the TMEM236 gene

• Protein detection: Use validated TMEM236 antibodies in Western blotting to confirm protein elimination

• Functional validation: Assess phenotypic changes, such as enhanced viral replication, which has been observed in TMEM236 knockout cells

What cell models are appropriate for studying TMEM236 function?

Based on current research, appropriate cell models include:

• MA104 cells (African green monkey kidney cells): Used successfully in CRISPR/Cas9 screening that identified TMEM236 as an antiviral factor

• Vero cells: Demonstrated to support higher yields of live-attenuated rotavirus vaccine strains when TMEM236 was knocked out

• Intestinal epithelial cell lines: May be relevant as TMEM236 is highly expressed in the human small intestine

What evidence supports TMEM236's role as an antiviral factor?

Several experimental findings support TMEM236's antiviral role:

• Genome-wide CRISPR/Cas9 screens identified TMEM236 as one of the top antiviral factors against rotavirus

• TMEM236 knockout cells showed significantly increased virus infectivity as early as 8 hours post-infection

• Disruption of TMEM236 was associated with notably increased plaque sizes and virus titers for multiple rotavirus strains (RRV, UK, and WI61)

• TMEM236 overexpression in MA104 cells inhibited rotavirus infection

• TMEM236 knockout also enhanced replication of rVSV-SARS-CoV-2, suggesting broader antiviral activity

How does TMEM236 expression vary across tissues and what are the implications?

TMEM236 is expressed at high levels in the human small intestine , which is significant considering that rotavirus has a tropism for intestinal tissues. This correlation suggests that TMEM236 may be part of the natural defense mechanism in tissues commonly targeted by certain viruses. Researchers investigating tissue-specific antiviral mechanisms should consider this expression pattern when designing experiments to understand TMEM236's physiological role.

Can TMEM236 function be manipulated to enhance vaccine production?

Yes, studies have demonstrated that TMEM236 knockout in Vero cells supported higher yields of two live-attenuated rotavirus vaccine strains compared to the parental cell line . This finding suggests that TMEM236-knockout cell lines could serve as improved substrates for vaccine production. For researchers working on vaccine development, generating TMEM236-knockout cell lines may be a valuable strategy to enhance the production efficiency of attenuated viral vaccines.

How can I design effective CRISPR/Cas9 strategies to study TMEM236 function?

To effectively target TMEM236 using CRISPR/Cas9:

• Select sgRNAs with high specificity and efficiency (previous studies have identified effective sgRNAs for TMEM236)

• Consider using lentiviral delivery systems for stable expression of CRISPR components (lenti-CRISPR_v2-based systems have been successfully employed)

• Implement appropriate selection methods (puromycin selection has been used successfully)

• Verify knockout through sequencing and functional assays as mentioned earlier

• Generate multiple individual knockout clones to account for potential clone-specific effects

What methodological approaches are available to study the mechanism of TMEM236's antiviral activity?

To elucidate the mechanisms behind TMEM236's antiviral activity, consider:

• Viral lifecycle stage analysis: Determine which stage of viral replication is affected (entry, uncoating, replication, assembly, or release)

• Protein interaction studies: Use co-immunoprecipitation with TMEM236 antibodies followed by mass spectrometry to identify binding partners

• Subcellular localization studies: Use immunofluorescence to track TMEM236 localization during viral infection

• Domain mapping: Generate truncated versions of TMEM236 to identify functional domains

• Comparative studies across multiple virus types: Assess whether the mechanism is conserved for different viruses

How can RNA-seq and proteomics complement TMEM236 antibody-based studies?

Integrating RNA-seq and proteomics with antibody-based studies provides a comprehensive understanding of TMEM236 function:

• RNA-seq analysis of TMEM236 knockout versus wild-type cells can reveal downstream pathways affected by TMEM236

• Temporal proteomics during viral infection can identify proteins that interact with TMEM236 at different stages

• Phosphoproteomics can uncover potential regulatory mechanisms affecting TMEM236 function

• Antibody-based pulldown followed by mass spectrometry can validate protein interactions identified through other methods

• Combined approaches can help distinguish direct versus indirect effects of TMEM236 on viral replication

How should researchers account for potential off-target effects when interpreting results from TMEM236 knockout studies?

To address off-target concerns:

• Use multiple sgRNAs targeting different regions of TMEM236 to confirm consistent phenotypes

• Perform rescue experiments by re-expressing TMEM236 in knockout cells to restore the wild-type phenotype

• Analyze potential off-target sites through computational prediction and targeted sequencing

• Compare results from knockout, knockdown, and overexpression studies to establish consistent functional patterns

• Utilize alternative gene editing approaches (e.g., base editing or prime editing) for validation

What are the key considerations when comparing results across different viral strains in TMEM236 studies?

When comparing TMEM236's effects across viral strains:

• Account for differences in viral entry mechanisms, which may be differentially affected by TMEM236

• Consider strain-specific replication kinetics when designing time points for analysis

• Normalize data appropriately based on the baseline replication efficiency of each strain

• Evaluate whether TMEM236's mechanism of action may differ between viral families

• Examine potential strain-specific adaptations that might counteract TMEM236 restriction

How can contradictory results between in vitro and in vivo TMEM236 studies be reconciled?

When facing contradictory results:

• Evaluate differences in TMEM236 expression levels between cell culture systems and tissues

• Consider the influence of immune system components present in vivo but absent in vitro

• Assess potential compensatory mechanisms that might be activated in vivo

• Examine tissue-specific factors that might modulate TMEM236 function

• Design experiments that bridge the gap between systems, such as organoid models that better recapitulate in vivo conditions